MAAS:NASDAQMaase Inc. Analysis
Data as of 2026-06-12 - not real-time
$13.50
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Technical momentum is bullish – the 20‑day SMA (≈11.20) sits well above the 50‑day (≈9.58) and 200‑day (≈5.87) averages, the MACD line is above its signal, and the histogram remains positive. However, the RSI is at 71, indicating the stock is overbought, and price is flirting with the identified resistance around $13.5.
Fundamentally the company is severely overvalued – a DCF fair‑value estimate of roughly $0.007 contrasts sharply with the current $13.5 market price, while margins are deeply negative (gross ~35%, operating ~‑57%) and earnings per share are –$3.22. The firm reports a staggering 71% 30‑day volatility, a beta of 2.75, and a max drawdown of –71%, underscoring high market risk. Recent news highlights strategic moves, such as a healthcare acquisition and AI‑centric green‑energy collaborations, which could provide future growth catalysts but do not yet offset the current financial weakness.
Fundamentally the company is severely overvalued – a DCF fair‑value estimate of roughly $0.007 contrasts sharply with the current $13.5 market price, while margins are deeply negative (gross ~35%, operating ~‑57%) and earnings per share are –$3.22. The firm reports a staggering 71% 30‑day volatility, a beta of 2.75, and a max drawdown of –71%, underscoring high market risk. Recent news highlights strategic moves, such as a healthcare acquisition and AI‑centric green‑energy collaborations, which could provide future growth catalysts but do not yet offset the current financial weakness.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Overbought RSI suggesting near‑term pullback
- Strong bullish technical indicators (SMA crossover, MACD)
- High volatility and beta increasing price swing risk
Medium Term
1–3 yearsCautious
Model confidence: 6/10
Key Factors
- Severe overvaluation versus DCF fair value
- Negative profitability and earnings
- Elevated regulatory and geographic risk in China
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- Strategic acquisitions and AI/green‑energy initiatives
- Potential for operational cash flow improvement
- Continued uncertainty around earnings recovery and regulatory environment
Key Metrics & Analysis
Financial Health
Profit Margin-50.96%
ROE-0.19%
ROA-0.13%
P/B Ratio0.0
Op. Cash Flow$10.2M
Free Cash Flow$230.0K
Industry P/E16.9
Technical Analysis
TrendBullish
RSI70.9
Support$9.30
Resistance$13.50
MA 20$11.20
MA 50$9.58
MA 200$5.87
MACDBullish
VolumeIncreasing
Fear & Greed Index88.09
Valuation
Fair Value$0.01
GradeOvervalued
TypeBlend
Risk Assessment
Beta2.75
Volatility71.91%
Sector RiskHigh
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.